News for hackers. Stuff that matters.
Re:HIV Is Reported Cured in a Second Patient by adrianratnapala on Tuesday March 05, 2019 @07:32PM (#19315503)
> For those stuck in the United States, the FDA will let you get Ocrelizumab, which is basically Rituximab tweaked enough so that Genentech could get patent protection for it.

So Rituximab was never approved by the FDA? I assume it too had once been under patent, and its manufacturer would have tried to get it approved.

Re:HIV Is Reported Cured in a Second Patient by steelframe on Monday March 11, 2019 @10:51PM (#19364935)
In the U.S., the FDA approves a drug for a particular use. Rituximab would have to undergo a complete set of clinical trials to show its safety and efficacy for MS in particular. Otherwise doctors can only prescribe it off-label, and the system (i.e., liability) is set up to dissuade doctors from prescribing drugs off-label if there exists a drug approved by the FDA for the particular purpose.